Healthcare Data Monetization Market Report: Insights and Future Prospects United States of America —The Insight Partners is pleased to announce the release of its new market report, "Healthcare Data Monetization Market: Comprehensive Analysis and Forecast." This report offers a deep dive into the healthcare data monetization market, discussing major trends, drivers of growth, and future opportunities. Overview of the Healthcare Data Monetization Market Healthcare data monetization is witnessing a high growth rate, driven by the escalating worth of health data and the requirement for creative solutions in healthcare provision. This report provides essential information on market trends, market competition, and technological innovation that will define the future of healthcare data monetization. Key Findings and Insights Market Size and Growth Historical Information: The Healthcare Data Monetization Market is expected to register a CAGR of 18.8% from 2025 to 2031, underpinned by increasing requirements for data-driven decision-making within healthcare. Key Drivers: The market growth is driven by Growing use of electronic health records (EHR) and health information exchanges (HIE) Increasing focus on personalized medicine and patient-centered care Regulatory encouragement for data sharing and interoperability Market Segmentation Segmentation Criteria: Method • Data as a Service • Insight as a Service • Analytics-enabled Platform as a Service • Embedded Analytics Organization • Large enterprises • Small & Medium Enterprises End-user • Pharmaceutical and Biotechnology Companies • Healthcare Players • Medical Technology Companies Emerging Trends Technological Advancements: Major technologies driving the healthcare data monetization market are Artificial Intelligence (AI) and Machine Learning (ML) for data analytics and predictive modeling Blockchain technology for secure data exchange and protection of privacy Changing Consumer Preferences: Growing trend towards Demand for transparency in data and control by patients over their personal health data Greater emphasis on value-based care models and outcomes measurement Regulatory Landscape: Adherence to developing healthcare regulations is pushing data monetization strategies innovation. Growth Opportunities The market for healthcare data monetization offers many opportunities for growth, such as Expansion into emerging markets with rising healthcare digitization Collaboration of healthcare organizations with technology companies for cutting-edge data solutions Research and development investment in next-generation analytics and data management solutions Conclusion The Healthcare Data Monetization Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2025-2031 report is a vital reference for stakeholders who wish to prepare themselves for the changing times of healthcare data monetization. Based on in-depth analysis of the market trend, competitive positioning, and growth opportunities, businesses can make conscious choices that can maximize their market influence. About The Insight Partners The Insight Partners is a prominent market research and consulting company committed to providing high-quality reports and strategic insights in numerous industries. Our robust research methodology utilizes both primary and secondary research to ensure that our clients are provided with accurate and actionable information. We are dedicated to assisting companies in navigating challenges and capitalizing on opportunities in their respective markets. Visit our website [here](homepage link) to learn more and access our full range of reports. https://www.theinsightpartners.com/en/reports/healthcare-data-monetization-market

Pigmentation Disorders Treatment Market Report: Unveiling the Growth Potential and Challenge United States of America— The Insight Partners is excited to announce its latest market report, "Pigmentation Disorders Treatment Market: An In-depth Analysis." The report gives a complete overview of the Pigmentation Disorders Treatment Market and gives the current situation and growth figures for the forecast period. Overview of Pigmentation Disorders Treatment Market The treatment market for pigmentation disorders has experienced significant developments, including expansion and changing dynamics. The report provides insights into the forces driving these dynamics, including changes in treatments, regulatory efforts, and changing consumer dynamics. Key Findings and Insights Market Size and Growth Historical Data: The Pigmentation Disorders Treatment Market is expected to register a CAGR of 5.9% from 2025 to 2031. Such information plays a key role in highlighting the market dynamics and making future estimations. Key Factors: Key factors responsible for the Pigmentation Disorders Treatment Market are Growing incidence of skin disorders Increased awareness of cosmetic treatments Technological advancements in dermatological treatments Market Segmentation Disorder Type • Melasma • Vitiligo • Albinism • Post-Inflammatory Hyperpigmentation Drug Type • Corticosteroids • Calcineurin Inhibitors • Janus kinase inhibitor • Melanin Synthesis Inhibitor Route of Administration • Oral • Topical Distribution Channel • Hospital Pharmacies • Retail Pharmacies • Online Pharmacies Identifying Emerging Trends Technological Developments: New and emerging technologies disrupting the pigmentation disorders treatment market are Emergence of new topical agents Sophisticated laser technologies for skin renewal Genetic and individualized medicine paradigms Shifting Consumer Preferences: Consumer preferences are changing towards Minimally invasive treatments Organic and natural treatment modalities Greater emphasis on preventive skincare Regulatory Changes: New regulatory changes supporting safety and effectiveness in dermatologic products are having a major influence on the Pigmentation Disorders Treatment market. Growth Opportunities The Pigmentation Disorders Treatment Market offers a number of growth opportunities, such As Emerging market expansion with expanding healthcare access New therapy development focused on individual pigmentation disorders. Partnerships between pharmaceutical firms and research organizations to increase treatment effectiveness Conclusion The Pigmentation Disorders Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2025-2031 market research report offers valuable information for organizations considering venturing into the pigmentation disorders market. By closely examining competitive forces, market situation, and avenues for growth, entrepreneurs and business leaders can make unbiased, fact-based decisions to ensure market success and maximize business opportunities. About The Insight Partners The Insight Partners is one of the world's leading market research and consulting companies. We pride ourselves on publishing exclusive reports along with high-end strategic and tactical analysis into diverse industries. We produce our reports through a blend of primary and secondary research, with an intention to present our clients with knowledge-based information on the market. This helps the clients make sound business decisions. A comprehensive approach in all our studies is an important component of our research methodology, which is why our reports are distinct and credible. Read more on our website [here](homepage link) and get full access to our reports. https://www.theinsightpartners.com/en/reports/pigmentation-disorders-treatment-market

Non-Viral Drug Delivery Systems Market to Witness Promising Growth Opportunities by 2024-2035 Date of Publication: 30-05-2025 The report titled ‘Non-Viral Drug Delivery Systems Market’ delivers a structured overview of how the industry has progressed over the years, along with expectations for future movement between 2025 and 2035. This report evaluates changes in the market size and highlights important developments within the industry. It offers clarity on regional patterns, key segments, and broader structural shifts without relying on speculative forecasting. The global non-viral drug delivery systems market size is estimated to be $8.6 billion in 2025 and is projected to reach $20.4 billion by 2035. The market is anticipated to grow at a CAGR of 9.0%, during the forecast period till 2035.. These projections are supported by current and historical performance metrics, highlighting regional and segment-level shifts across the global landscape. The study also outlines some of the major challenges and approaches being used across industry to adapt to evolving market conditions. The market forecast section provides a grounded view of potential movements over time, based on verified data and observed patterns. Source of information: - https://www.rootsanalysis.com/reports/non-viral-drug-delivery-systems-market.html This report includes a complete segmentation of the Non-Viral Drug Delivery Systems Market. The segmentation is based on Distribution by Type of Biologic Delivered, Type of Vehicle Used, Target Therapeutic Area, Type of Payment Employed, Key Geographical Regions, Companies Profiled. Key Geographies • Arcturus Therapeutics, Bio-Path Holdings, CureVac, Entos Pharmaceuticals, etherna, Matinas Biopharma, MDimune, PCI Biotech In addition to a high-level overview, the report also discusses market share shifts across these regions and the economic performance within each geography. It presents reliable estimates of projected revenue and market contribution, maintaining a neutral stance on causal relationships or future assumptions. Emphasis is placed on identifying key structural elements influencing Non-Viral Drug Delivery Systems Market growth across different regional and application-based divisions. The report features a detailed assessment of leading market participants, highlighting companies such as Arcturus Therapeutics, Bio-Path Holdings, CureVac, Entos Pharmaceuticals, etherna, Matinas Biopharma, MDimune, PCI Biotech. These companies have been profiled based on product focus, regional activity, and general business operations. The section on top companies in Non-Viral Drug Delivery Systems Market also evaluates how these firms have positioned themselves in response to market shifts, and how their current portfolios align with observed demand. Additional insights include the review of pricing models, cost structures, and supply chain operations relevant to the Non-Viral Drug Delivery Systems Market. The report includes discussion on raw material access, cost flow, distribution patterns, and processing rates, offering a deeper look at how value is created and maintained across different stages of production and delivery. The study also references recent strategic activities such as acquisitions, product launches, and geographic expansions. These developments are discussed in the context of how they impact competitive intensity and operational shifts within the Non-Viral Drug Delivery Systems Market. The analysis remains factual, highlighting observed actions without assigning subjective or future-looking projections. Research Methodology The methodology for this report includes both primary and secondary data collection from credible industry sources. Analysts have compiled information from public filings, interviews, industry portals, and market databases to ensure a high standard of accuracy. This approach ensures that the data used in the Non-Viral Drug Delivery Systems Market analysis is robust and suitable for industry decision-making. For any questions or to request a customized version of this report, please connect with our team. We’re available to help tailor the study to your specific needs and areas of interest. About Roots Analysis Roots Analysis is a leading business research and consulting firm known for its top-notch competitive intelligence, market research, and tailored consulting services. They dive deep into industries such as pharmaceuticals, biotechnology, medical devices, semiconductors and electronics, chemicals and materials, and information and communication technology, delivering high-quality analysis and practical insights. By offering customized solutions like market landscape mapping, competitive benchmarking, and opportunity analysis, Roots Analysis helps clients navigate complex markets and unlock growth with clear, data-driven strategies.

Global Pharmaceutical glass packaging market is expected to grow at a significant rate of around 8% during the forecast period. Offering protection, presentation, identity, information convenience, and compliance for a drug and medicine throughout storage, carriage, and exhibition is referred to as pharmaceutical glass packaging. https://univdatos.com/reports/pharmaceutical-glass-packaging-market

Atopic Dermatitis Market Size, Demand, Analytical Overview, Comprehensive Analysis, Segmentation, Competitive Landscape 2035 The latest report entitled‘Atopic Dermatitis Market’ by Roots Analysis provides an accurate estimation of the market size, regional landscape description, and revenue forecast over the projected timeframe. The atopic dermatitis market size is projected to grow from USD 13.69 billion in 2025 to USD 31.86 billion by 2035, representing a CAGR of 8.81% during the forecast period till 2035. The report turns the spotlight on the major challenges faced by the key players in the global market and the growth strategies currently adopted by them. The report is a granular assessment of this particular business sphere and entirely covers the dynamic competitive landscape of the market. The document offers key insights into the market positions of these players alongside their gross earnings. Furthermore, it elaborates on each of the market segments, with detailed scrutiny of the development scope and competitive scenario of the regional fragments of the market. The latest study is inclusive of an in-depth analysis of the economic status of the Atopic Dermatitis Market and examines the most important regions constituting the global market. It further details on the most lucrative and growth-oriented regions, top market rivals, diversified product types, and a large number of end-use industries. Key factors affecting the growth of the Atopic Dermatitis Industry: Geographical Overview: • The latest report broadly categorizes the Atopic Dermatitis Market into several geographical terrains, including AbbVie, Anacor Pharmaceuticals, Bayer, Eli Lily and Company, Encore Dermatology, Galderma Laboratories, Incyte, LEO Pharma, MedPointe Pharmaceutical, Novartis AG, Otsuka Pharmaceutical, Pfizer, Regeneron Pharmaceuticals, Sanofi. • The study is inclusive of essential information relevant to each region in this broad industry segment, along with the key drivers of the regional market growth. • The report further estimates the revenue accumulated by these regions over the forecast period. Competitive Hierarchy: • The latest research report studies the major market players, their regional presence, industry share, and production facilities. • The report offers significant data pertaining to these market competitors’ company profiles, product types, and application outlook. • Moreover, the pricing models and gross margins of these industry majors have also been mentioned in the report. Key companies in theAtopic Dermatitis Market: AbbVie, Anacor Pharmaceuticals, Bayer, Eli Lily and Company, Encore Dermatology, Galderma Laboratories, Incyte, LEO Pharma, MedPointe Pharmaceutical, Novartis AG, Otsuka Pharmaceutical, Pfizer, Regeneron Pharmaceuticals, Sanofi. Additional parameters of the Atopic Dermatitis Market report: The latest research study endows the reader with a comprehensive analysis of the product types of the Atopic Dermatitis industry, categorizing the relevant information into the Distribution by Type of Drug, Route of Administration, Type of Distribution Channel, Geographical Regions, Leading Market Players, PowerPoint Presentation(Complimentary). The study focuses on the wide-ranging application landscape of the market, segmenting it into the market share, estimated growth rate, and the forecast product demand for each application type. Additional Insights: • The market concentration rate and processing rate of raw materials have also been conscripted in the report. • The report contains an assessment of the current price trends, as well as the factors influencing the global market size. • It throws light on the significant marketing strategies implemented by the eminent players in the industry. • Vital data and information concerning the producers, distributors, and downstream buyers involved in the global market, as well as the cost structure analysis and market mechanism, form the important elements of this report. Read More :- https://www.rootsanalysis.com/reports/atopic-dermatitis-market.html

Soft Tissue Sarcoma Market Size, Share, Growth Factors, Competitive Landscape, with Regional Forecast to 2035 The soft tissue sarcoma market is experiencing significant growth, driven by increasing disease prevalence, advancements in treatment options, and expanding research efforts. The market size was valued at approximately $3.15 billion in 2024 and is projected to grow to $3.42 billion by 2025, reflecting a compound annual growth rate (CAGR) of around 8.6% during this period. Further growth is expected, with forecasts estimating the market to reach $4.76 billion by 2029[1][5]. Drivers of Market Growth Several factors contribute to the robust expansion of the soft tissue sarcoma market: - Increasing Incidence: According to the American Cancer Society, an estimated 13,400 new cases of soft tissue sarcoma were expected in 2023, with a significant mortality rate due to delayed diagnosis and advanced disease stages. This growing patient population fuels demand for effective therapies[2]. - Advancements in Treatment: The development of targeted therapies, immunotherapies, and combination treatments is enhancing clinical outcomes. Innovations such as precision medicine, liquid biopsies, and genomic research breakthroughs are shaping the future treatment landscape[5]. - R&D Investment and Government Support: There is a surge in research and development activities focused on novel drug candidates and therapeutic approaches. Government initiatives and increased funding for cancer research further support market growth[2][3]. - Improved Healthcare Infrastructure: Enhanced access to healthcare services and therapies worldwide provides a promising environment for market expansion[2][3]. Market Segmentation and Application Areas The market analysis covers a comprehensive pipeline of marketed, clinical, and preclinical molecules for soft tissue sarcoma treatment. The report segments the therapeutic products by development stage, product type, route of administration, molecule type, and mechanism of action. It also examines current treatment practices and emerging drugs, providing insights into dosage, administration, pharmacology, and regulatory milestones. Challenges in the Market Key challenges include the complexity of soft tissue sarcoma diagnosis, the heterogeneity of the disease, and the limited range of effective treatment options currently available. Delayed diagnosis and the advanced stage at which many patients present contribute to high mortality rates, underscoring the need for earlier detection and improved therapies[2]. Key Players and Competitive Landscape The market features active participation from major pharmaceutical companies such as Pfizer, Eli Lilly, Johnson & Johnson, GlaxoSmithKline (GSK), and Roche, among others. These players are engaged in developing new drugs and combination therapies, supported by collaborations, licensing agreements, and investments across various stages of drug development[3]. Research and Clinical Development The report highlights ongoing and planned clinical trials, analyzing parameters such as trial phase, patient enrollment, study design, and geographic distribution. It also identifies key opinion leaders and industry experts contributing to clinical research, providing a detailed view of the competitive and collaborative landscape. Future Outlook The soft tissue sarcoma market is poised for continued growth through 2035, driven by: - Expansion of targeted and immunotherapy treatments - Increased adoption of precision medicine approaches - Growth in clinical trial activity and early detection initiatives - Enhanced patient-centered care models and innovative diagnostic tools These trends, combined with rising disease prevalence and supportive healthcare infrastructure, are expected to sustain market momentum over the next decade[5]. Read More :- https://www.rootsanalysis.com/reports/soft-tissue-sarcoma-market.html

Whole Genome Sequencing Market Growth and Status Explored in a New Research Report 2035 The latest report published by Roots Analysis, titled Whole Genome Sequencing Market offers a detailed study of the industry size, growth scenarios, and fundamental parameters of the market analysis. In this research report, the author provided an in-depth analysis of market dynamics, including key drivers, restraints, opportunities, and major threats that may impact growth during the upcoming years. Our market analysis report provides a brief discussion on leading market players, the competition landscape, regional dominance, supply-demand ratio, business strategies, and future investment opportunities in the overall industry. This report provides a complete prototype of the estimated growth rate, market value, product types, applications, and type of end users active in this industry. Get a sample of the report @ https://www.rootsanalysis.com/reports/whole-genome-sequencing-market/request-sample.html Global Whole Genome Sequencing Market Size Overview The global Whole Genome Sequencing market is witnessing an upward trajectory owing to the growing demand for Whole Genome Sequencing products. In this market study report, authors have covered a comprehensive analysis on current market size and future growth during the projected period. The latest insightful information on market size and future growth opportunities serves as a valuable document to make business decisions promptly. Global Whole Genome Sequencing Market Dynamics Insight In this exclusive report on the global Whole Genome Sequencing market, our researcher offers an illustrative study on major market dynamics including competitive landscape, industry outlook, skeptical study on major threats and growth opportunities. Competitive Landscape of Whole Genome Sequencing Market: Our latest market research report on the Whole Genome Sequencing market offers an exclusive analysis of the competitive landscape, key players, and company profiles. In order to leverage a competitive edge, the active players in this industry have taken strategic initiatives such as mergers & acquisitions, business deals, collaborations, technological advancements, joint ventures, and the latest product launches. Key Companies Profiled in the Report are • Agilent Technologies • Azenta Life Sciences (GENEWIZ) • BGI • Illumina • Oxford Nanopore Technologies • ProPhase Labs (Nebula Genomics) • Pacific Biosciences • Psomagen • QIAGEN • Thermo Fisher Scientific Whole Genome Sequencing Market: Industry Trends and Global Forecast, Till 2035: Distribution by Type of Product (Instruments, Consumables and Services), Type of Sequencing (Large Whole Genome Sequencing and Small Whole Genome Sequencing), Type of Workflow (Pre-Sequencing, Sequencing and Data Analysis), Type of Application (Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing and Microbial Whole Genome Sequencing), By End-User (Academic & Research Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Other End Users). Global Whole Genome Sequencing Market Statistical Analysis The report also covers a detailed discussion of various market segments and competitive scenarios, such as policy implementation and regulatory standards across the industry. Our robust team of research analysts utilized standardized analytical tools such as SWOT analysis and Porter's Five Forces analysis to provide a brief overview of the fundamental growth trends and projected growth rate during the forecast period. To know more about the report, visit https://www.rootsanalysis.com/reports/whole-genome-sequencing-market.html About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, and venture and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serving our clients in the best possible way. Contact Details Roots Analysis Gaurav Chaudhary +1 (415) 800 3415 +44 (122) 391 1091 Gaurav.chaudhary@rootsanalysis.com Website: https://www.rootsanalysis.com/

CAR T-cell therapy Market Growth and Status Explored in a New Research Report 2035 Cancer therapeutics continue to be one of the most active areas, in terms of drug development, there is still a significant unmet need in this domain. In fact, conventional cancer treatments, such as chemotherapy, surgery and radiation therapy, have demonstrated very limited efficacy in late-stage cancers. The global CAR T-cell therapy market size is projected to grow from USD 4.6 billion in 2024 to USD 15.2 billion by 2035, growing at a CAGR of 11.4% during the period, till 2035. Amidst the current initiatives to develop more targeted anti-cancer therapies, immunotherapy has emerged as a highly potent option to selectively eliminate tumor cells with minimal side effects. Immunotherapies essentially make use of the body’s own immune system, or its components, to fight cancer. It is a relatively new concept, currently having achieved pharmacological success with targeted antibody-based therapeutics, including monoclonal and conjugated antibodies. However, over the years, different classes of immunotherapies have emerged for the management and treatment of cancer; these include therapeutic cancer vaccines, oncolytic viruses, cytokines, immune checkpoint inhibitors and certain whole cell-based therapies (adoptive cell therapies). The CAR T cell therapy market landscape has transformed significantly over the past two decades. Currently, more than 330 players claim to provide CAR-T cell therapies across different developed geographies. More than 75% of the therapy candidates, which are being developed to target a range of disease indications, are autologous in nature. Further, CD19 and BCMA have emerged as the most popular target antigens. A rise in partnerships, in the recent past, involving both international and indigenous stakeholders, validate the growing interest in this domain; maximum number of such deals were signed in 2021. Majority of the partnership instances are intracontinental. Additionally, close to 50% of the total number of partnerships have been signed between the players based in North America. Further, for majority of the intercontinental agreements, companies headquartered in Europe have collaborated with players based in North America. Several investors, having realized the opportunity within this upcoming segment of cancer immunotherapy, have invested close to USD 32.4 billion, across 260+ instances, during the period pre2014-2024. Majority of the patents in this domain are patent applications (84%), followed by granted patents (13%). In addition, most of the patents (54%) were filed / granted in North America. This is followed by patents filed / granted in Europe (19%). Research Methodology Our analysts have performed an accurate examination of the various aspects of the global market leveraging avant-garde primary and secondary sources of data collection. The report has gathered the necessary data and information from several reliable sources. Additionally, the report offers many strategic recommendations for companies involved in this ever-growing business sector to help them attain a competitive edge in the Car T-cell therapy Market. Thank you for reading our report. Kindly get in touch with us to know more about the report or to receive a customized copy of it. Our team will ensure the report is tailored according to your needs. To view more details on this report, click on the link https://www.rootsanalysis.com/reports/car-t-cell-therapy-market/269.html About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. We specialise in analysing areas which have lacked quality research so far or require more focused understanding within the broader industry. All our reports are structured in a way to enable the reader develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we also provide bespoke research / consulting services dedicated to serve our clients in the best possible way. The research efforts are driven by a global team. The leadership team brings a wealth of experience within the sector. Their collective experience in pharmaceutical / affiliated domains allows us to tackle various areas of research in a structured way. We also regularly leverage our global network of experts who hold senior leadership positions in reputed firms and organisations worldwide. Contact: Roots Analysis +1 (415) 800 3415 Sales@rootsanalysis.com

Insulin Pump Market Key Highlights and Future Opportunities Till 2035 Insulin pumps: bridging the gap to improve diabetes control- In recent decades, the prevalence of diabetes has risen dramatically worldwide; it is worth mentioning that diabetes affects more than 420 million people globally. The insulin pump market size is projected to grow from $ 5.8 billion in 2024 to $ 13.6 billion by 2035, representing a CAGR of 8% during the forecast period till 2035. Dyring our research, we identified 30 players that are engaged in manufacturing insulin pumps. The insulin pumps industry is well-fragmented, comprising of established companies and emerging enterprises competing in the market. Notably, around 20% of the companies were set up post-2012, indicating dynamic opportunities for innovation and growth in this sector. Over 40% of the players in this domain are headquartered in North America, followed by companies headquartered in Europe and Asia-Pacific. In addition, 45% of the insulin pump manufacturers are large and very large firms. Insulin Pump Market: Industry Trends and Global Forecasts, till 2035 - Distribution by Type of Pump (Tethered Pumps and Patch Pumps), Degree of Automation (Manual Pumps and Automated / Smart Pumps), Type of Battery (Replaceable Batteries and Rechargeable Batteries), Type of Diabetes Targeted (Type 1 Diabetes and Type 2 Diabetes), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies and Other Pharmacies) and Key Geography (North America, Europe, Asia, Latin America and, Middle East and North Africa) Increase in the intellectual capital- an evidence for progression in R&D activity for insulin pumps- Over 1,600 patents related to insulin pumps have been filed / granted, indicating the heightened pace of innovation in this domain. Notably, around 35% of the patents were published in 2022, followed by those published in 2023 (31%). Further, most (~55%) of the patents in this domain were patent applications. Despite the large number of patents that have been filed recently (and hence having a long remaining patent life), only 1% of the total patents filed in this domain have a significantly higher relative valuation. This is primarily because of the relatively low citations of the patents that have been filed recently, leading to low patent value. It is worth mentioning that Medtronic leads in insulin pump patent filings, demonstrating its strong commitment to advancing glucose management through designing of innovative pumps. Research Methodology Our analysts have performed an accurate examination of the various aspects of the global market leveraging avant-garde primary and secondary sources of data collection. The report has gathered the necessary data and information from several reliable sources. Additionally, the report offers many strategic recommendations for companies involved in this ever-growing business sector to help them attain a competitive edge in the Insulin pump Market. Thank you for reading our report. Kindly get in touch with us to know more about the report or to receive a customized copy of it. Our team will ensure the report is tailored according to your needs. To view more details on this report, click on the link https://www.rootsanalysis.com/reports/insulin-pump-market.html About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. We specialise in analysing areas which have lacked quality research so far or require more focused understanding within the broader industry. All our reports are structured in a way to enable the reader develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we also provide bespoke research / consulting services dedicated to serve our clients in the best possible way. The research efforts are driven by a global team. The leadership team brings a wealth of experience within the sector. Their collective experience in pharmaceutical / affiliated domains allows us to tackle various areas of research in a structured way. We also regularly leverage our global network of experts who hold senior leadership positions in reputed firms and organisations worldwide. Contact: Roots Analysis +1 (415) 800 3415 Sales@rootsanalysis.com

Quantum computing Market Growth and Development: Regional Demand, Segment by Types and End-User By 2035 Drug discovery has always been a time-consuming process. On an average, it takes 10-15 years and capital investments worth USD 4-10 billion to commercially launch a drug. The global quantum computing market size is estimated to grow from USD 0.39 billion in 2024 to USD 1.63 billion by 2035, representing a CAGR of 13.86% during the forecast period till 2035. It involves various processes such as target identification, validation, hit generation, hit to lead and lead optimization. The term quantum computing refers to the technology that uses laws of quantum mechanics to solve large and complex problems in a short span as compared to the computer aided drug discovery. During our research, we were able to identify the presence of about 50 software providers that are engaged in offering services across drug discovery. Majority of the quantum computing software providers (45%) engaged in this domain were established post-2016. This is indicative of the growing interest of stakeholders in this domain. Examples of recently established companies include (post-2019, in alphabetical order) Algorithmiq (2020), Kuano (2020), Polaris Quantum Biotech (2020), Qubit Pharmaceuticals (2020) and Qunova Computing (2021). Additionally, 16% companies have entered this domain before 2000, indicating that the market is driven by efforts of well-established players as well. Further, it was observed that majority of players offer platform / software (98%) as a business capability followed by Quantum as a Service (69%). In addition to this 10% of the players offer platform capabilities for Drug Discovery and Drug Design. Majority (86%) of the players offer target discovery / identification as a drug discovery service followed by lead optimization (63%); examples of players offering all types of drug discovery service(s) include (in alphabetic order) Allesh Biosciences Lab, Hafnium Labs, Profacgen, Qsimulate and Roviant Discovery. The current market landscape is dominated by the presence of small companies (67%). Notable examples include (in alphabetical order) Aliro Quantum, Aqemia, Cloud Pharmaceuticals, Hafnium Labs, Phoremost and Qulab. In addition, the maximum number (19) of players are located in the US, followed by UK (5). Further, within the Asia-Pacific region, India emerged as the leading country, with the presence of four companies, including (in alphabetical order) Allesh Biosciences Lab, QpiAI, Qulab and Xanadu. Further, quantum computing software providers, focuses on various therapeutic area(s) primarily includes oncological disorders (67%) followed by infectious diseases (62%). It is worth noting that Denovicon Therapeutics offers software focusing on all types of therapeutic area(s). To view more details on this report, click on the link https://www.rootsanalysis.com/reports/quantum-computing-in-drug-discovery.html About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. We specialise in analysing areas which have lacked quality research so far or require more focused understanding within the broader industry. All our reports are structured in a way to enable the reader develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we also provide bespoke research / consulting services dedicated to serve our clients in the best possible way. The research efforts are driven by a global team. The leadership team brings a wealth of experience within the sector. Their collective experience in pharmaceutical / affiliated domains allows us to tackle various areas of research in a structured way. We also regularly leverage our global network of experts who hold senior leadership positions in reputed firms and organisations worldwide. Contact: Roots Analysis +1 (415) 800 3415 Sales@rootsanalysis.com